HIP1 as a marker of aggressive prostate cancer
Chan, E Y W (2002) HIP1 as a marker of aggressive prostate cancer. Clinical Genetics, 62 (5). pp. 372-375. ISSN 0009-9163 (https://doi.org/10.1034/j.1399-0004.2002.620503_4....)
Full text not available in this repository.Request a copyAbstract
A recent report from Theadora Ross’s group describes an exciting link between huntingtin interacting protein-1 (HIP1) and prostate cancer, providing further evidence for a critical role of this protein in the regulation of cell survival. HIP1 was initially identified by virtue of its interaction with huntingtin, the protein mutated in the neurodegenerative disorder Huntington disease (HD). The role of HIP1 in HD has been postulated to reflect a pro-apoptotic function in the cytoplasm (4,5).
-
-
Item type: Article ID code: 49625 Dates: DateEventNovember 2002PublishedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 06 Oct 2014 14:04 Last modified: 08 Apr 2024 21:42 URI: https://strathprints.strath.ac.uk/id/eprint/49625
CORE (COnnecting REpositories)